FFCP PHASE1:Hg19::chr15:44084151..44084155,+
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p14@SERF2, p4@C15orf63 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_14_at_SERF2_5end, CAGE_peak_4_at_C15orf63_5end |
Coexpression cluster: | NA |
Association with transcript: | -18bp_to_NM_001199875, NM_001199876, NR_037672, NR_037673, uc001zsz.3, uc001ztb.2, uc010bdq.2, uc010uee.1_5end |
EntrezGene: | 10169,100529067,25764 |
HGNC: | 18418&submit=Submit 10757, 18418 |
UniProt: | B9A026A6NL45 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p14@SERF2p4@C15orf63 |
---|
0.0
0.5
1.0
1.5
2.0
2.5
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
antibody secreting cell | 2.82e-21 | 1 |
plasma cell | 2.82e-21 | 1 |
plasmablast | 2.82e-21 | 1 |
CD34-positive, CD38-negative hematopoietic stem cell | 5.16e-21 | 1 |
mature B cell | 2.47e-11 | 2 |
pre-B-II cell | 2.47e-11 | 2 |
transitional stage B cell | 2.47e-11 | 2 |
small pre-B-II cell | 2.47e-11 | 2 |
immature B cell | 2.47e-11 | 2 |
precursor B cell | 5.54e-08 | 3 |
Showing 1 to 10 of 10 entries
Ontology term | p-value | n |
---|---|---|
anemia | 1.53e-21 | 1 |
hematopoietic system disease | 1.82e-11 | 2 |
peripheral nerve sheath neoplasm | 4.52e-11 | 2 |
neurofibroma | 4.52e-11 | 2 |
lymphoma | 6.04e-09 | 10 |
peripheral nervous system neoplasm | 8.29e-08 | 3 |
Showing 1 to 6 of 6 entries